Henry Ji is CEO & President at Sorrento Therapeutics, Inc. (SRNE). They have made 24 open-market trades across 2 companies since 2012, most recently 2026-04-17.
CIK 0001470981
24 open-market purchases totalling $3.3M since 2012, never a sale. Across 24 scored buys the stock is down 17.7% at ninety days, and 19.2 points behind the S&P over the same stretch.
24 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 25% | 13% | 13% |
| Avg Move | -11.0% | -5.2% | -17.7% |
| Alpha | -8.8% | -4.4% | -19.2% |
| Scored | 24 | 24 | 24 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SCLX | BUY | 2024-10-31 | 2024-10-31 | $0.94 | $8K | -19.9% | -33.2% | -53.1% |
| SCLX | BUY | 2024-10-17 | 2024-10-18 | $0.97 | $10K | -4.4% | -35.5% | -52.4% |
| SCLX | BUY | 2024-05-17 | 2024-05-17 | $0.88 | $44K | +13.3% | +119.4% | +26.5% |
| SRNE | BUY | 2022-09-07 | 2022-09-07 | $2.02 | $359K | -14.8% | -30.1% | -46.2% |
| SRNE | BUY | 2022-09-06 | 2022-09-06 | $1.96 | $218K | -3.6% | -19.6% | -38.7% |
| SRNE | BUY | 2022-08-26 | 2022-08-26 | $2.11 | $141K | +18.5% | -24.5% | -32.5% |
| SRNE | BUY | 2022-08-25 | 2022-08-25 | $2.06 | $46K | -1.8% | -30.4% | -36.4% |
| SRNE | BUY | 2022-06-14 | 2022-06-14 | $1.40 | $14K | +40.0% | +73.1% | +57.2% |
| SRNE | BUY | 2018-02-28 | 2018-02-28 | $9.95 | $643K | -18.9% | -52.7% | -21.4% |
| SRNE | BUY | 2017-06-15 | 2017-06-15 | $1.81 | $53K | +7.9% | +5.3% | -5.3% |
| SRNE | BUY | 2017-04-19 | 2017-04-19 | $2.00 | $200K | +8.3% | -12.5% | +11.1% |
| SRNE | BUY | 2017-02-22 | 2017-02-22 | $5.60 | $11K | -9.4% | -22.6% | -70.3% |
| SRNE | BUY | 2017-02-10 | 2017-02-10 | $5.15 | $103K | -5.5% | -20.9% | -68.2% |
| SRNE | BUY | 2017-02-03 | 2017-02-03 | $5.15 | $103K | +8.7% | -7.7% | -63.5% |
| SRNE | BUY | 2015-08-24 | 2015-08-24 | $12.84 | $114K | -28.1% | -3.2% | -3.2% |
| SRNE | BUY | 2015-08-21 | 2015-08-21 | $13.08 | $116K | -28.1% | -3.2% | -3.2% |
| SRNE | BUY | 2014-11-10 | 2014-11-10 | $4.83 | $29K | -28.1% | -3.2% | -3.2% |
| SRNE | BUY | 2014-11-07 | 2014-11-07 | $4.56 | $18K | -28.1% | -3.2% | -3.2% |
| SRNE | BUY | 2014-11-06 | 2014-11-06 | $4.53 | $14K | -28.1% | -3.2% | -3.2% |
| SRNE | BUY | 2013-12-05 | 2013-12-05 | $8.92 | $9K | -28.1% | -3.2% | -3.2% |
| SRNE | BUY | 2013-12-04 | 2013-12-05 | $8.54 | $9K | -28.1% | -3.2% | -3.2% |
| SRNE | BUY | 2013-11-22 | 2013-11-22 | $8.47 | $8K | -28.1% | -3.2% | -3.2% |
| SRNE | BUY | 2013-11-19 | 2013-11-20 | $8.60 | $17K | -28.1% | -3.2% | -3.2% |
| SRNE | BUY | 2012-05-15 | 2012-05-16 | $0.16 | $1.0M | -28.1% | -3.2% | -3.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.